Advances in biomarker sciences and technology最新文献

筛选
英文 中文
Faecal microbial transplant 粪便微生物移植
Advances in biomarker sciences and technology Pub Date : 2024-02-01 DOI: 10.1016/j.abst.2024.02.001
Onifade Isreal Ayobami, Oluwatomiwa Jubilee Sunbare-Funto, Chinedu Endurance Mbah, O. Ajibade, O. Oyawoye, A. Aborode, S. C. Ogunleye, A. Jamiu, Basit Bolarinwa, Mosope F. Abanikannda, Zainab Tiamiyu, A. R. Idowu, O. Ige, Opara Julia Kelechi, Jeremiah I. Abok, Eniola A. Lawal, Ibude Jane Aruorivwooghene, Adekunle Fatai Adeoye, Olowo Roqeebah, Emmanuel Akinloye Ojewole, R. Adesola
{"title":"Faecal microbial transplant","authors":"Onifade Isreal Ayobami, Oluwatomiwa Jubilee Sunbare-Funto, Chinedu Endurance Mbah, O. Ajibade, O. Oyawoye, A. Aborode, S. C. Ogunleye, A. Jamiu, Basit Bolarinwa, Mosope F. Abanikannda, Zainab Tiamiyu, A. R. Idowu, O. Ige, Opara Julia Kelechi, Jeremiah I. Abok, Eniola A. Lawal, Ibude Jane Aruorivwooghene, Adekunle Fatai Adeoye, Olowo Roqeebah, Emmanuel Akinloye Ojewole, R. Adesola","doi":"10.1016/j.abst.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.abst.2024.02.001","url":null,"abstract":"","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139817822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammation-induced cellular changes: Genetic mutations, oncogene impact, and novel glycoprotein biomarkers 炎症诱导的细胞变化:基因突变、癌基因影响和新型糖蛋白生物标记物
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.06.002
Xiaotong Wang , Yunqiu Shen , Yan Chen , Shuang Yang
{"title":"Inflammation-induced cellular changes: Genetic mutations, oncogene impact, and novel glycoprotein biomarkers","authors":"Xiaotong Wang ,&nbsp;Yunqiu Shen ,&nbsp;Yan Chen ,&nbsp;Shuang Yang","doi":"10.1016/j.abst.2024.06.002","DOIUrl":"https://doi.org/10.1016/j.abst.2024.06.002","url":null,"abstract":"<div><p>Persistent inflammation can trigger the development of colorectal cancer, especially in patients with inflammatory bowel disease (IBD). The precise molecular mechanisms underlying this process are not fully understood. This study investigated the molecular modifications that occur in the cellular microenvironment during inflammation-induced and colitis-associated cancers. Studies showed that genetic mutations and post-translational modifications of oncogene proteins can alter the biological functions of macrophage inflammatory proteins, complicating the intricate interactions between inflammation and cancer. The researchers also observed abnormal glycosylation patterns in cases of inflammation and colitis-associated cancers. This observation suggests that glycoproteins present in bodily fluids could potentially serve as valuable disease markers. Additionally, the researchers investigated general signaling alterations that manifest in cases of colitis-associated cancer. They proposed a provisional molecular model that suggests the involvement of endoplasmic reticulum (ER) stress during the transition from inflammation to cancer. This potential pathway is mediated through the FKBP/c-Myc/p53 signaling axis. In the context of protein glycosylation, we summarize the potential molecular mechanisms of IBD-induced carcinogenesis. This knowledge could potentially lead to the development of novel targets for the clinical treatment of colorectal cancer.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000097/pdfft?md5=718031484392d22ce87e2421b57cf8f9&pid=1-s2.0-S2543106424000097-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141438577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Matrix metalloproteinase 7 as a diagnostic biomarker of biliary atresia: A systematic review 基质金属蛋白酶7作为胆道闭锁的诊断生物标志物:系统综述
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.04.001
Pauline Louise Møllmann Lausten , Vibeke Brix Christensen , Hannelouise Kissow
{"title":"Matrix metalloproteinase 7 as a diagnostic biomarker of biliary atresia: A systematic review","authors":"Pauline Louise Møllmann Lausten ,&nbsp;Vibeke Brix Christensen ,&nbsp;Hannelouise Kissow","doi":"10.1016/j.abst.2024.04.001","DOIUrl":"10.1016/j.abst.2024.04.001","url":null,"abstract":"<div><h3>Background</h3><p>Biliary atresia (BA) is a disease of the intrahepatic or extrahepatic bile ducts with an unknown etiology. It presents in neonates with jaundice, clay-colored stool, and often hepatomegaly. Early diagnosis of the disease is pivotal for long-term prognosis. If the BA is left untreated, progressive liver cirrhosis and death can occur. Persisting jaundice in infants born at term should lead to further examination of liver diseases. A range of laboratory analyses is used, but none is specific for BA. In this review, we investigate whether the level of matrix metalloproteinase 7 (MMP-7) in serum can be used as an early diagnostic biomarker for BA.</p></div><div><h3>Method</h3><p>A systematic literature search of the PubMed database revealed the two terms “matrix metalloproteinase 7” and “biliary atresia”. A total of 24 articles were identified; these articles were screened, and eight articles were found to be relevant for this literature review, each describing an independent study.</p></div><div><h3>Results</h3><p>In all eight articles, the diagnostic cut-off values for serum MMP-7 in BA patients vs. non-BA patients were determined by receiver operating characteristic (ROC) curve analysis and by determining the area under the curve (AUC). The AUC ranged from 0.96 to 0.99. All studies had a sensitivity of 95 % or above and a specificity of 83 % or above. The cut-off values were discordant and ranged from 1.43 ng/ml to 52.85 ng/ml. The calculated positive likelihood ratio (PLR) varied from 5.66 to 21.86, and the negative likelihood ratio (NLR) varied from 0.01 to 0.05 among the eight studies. Finally, the diagnostic odds ratio (DOR) varied from 168.64 to 1406.00 in seven out of the eight studies.</p></div><div><h3>Conclusion</h3><p>The serum MMP-7 concentration can be used as a diagnostic biomarker according to the eight studies investigated in this review. However, further assessments of MMP-7 in larger, multicenter, and multiethnic studies are needed to validate its potential for biomarker development and, ultimately, its standard use in clinical practice.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000061/pdfft?md5=af95e4928e71a8f2814b306292f1fb85&pid=1-s2.0-S2543106424000061-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140771555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A systematic study on key Epigenetic modulators in post-stroke conditions 关于中风后关键表观遗传调节剂的系统研究
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.06.004
Dhruv Parikh , Manan Shah
{"title":"A systematic study on key Epigenetic modulators in post-stroke conditions","authors":"Dhruv Parikh ,&nbsp;Manan Shah","doi":"10.1016/j.abst.2024.06.004","DOIUrl":"https://doi.org/10.1016/j.abst.2024.06.004","url":null,"abstract":"<div><p>A stroke is a medical emergency characterized by the sudden interruption of blood flow to the brain, leading to cell death from oxygen deprivation. As a leading cause of mortality and long-term disability worldwide, strokes present a growing socioeconomic challenge, exacerbated by demographic shifts and an increasing incidence in younger populations. Analyzing post-stroke conditions is essential for predicting recovery trajectories and guiding personalized treatments. The process is crucial for mitigating long-term cognitive deficits and improving the quality of life for stroke survivors and their families. Epigenetic mechanisms are emerging as key influencers, with four significant modulators—miRNAs, lncRNAs, DNA methylation, and histone modifications—being identified as central to modulating neuronal repair and regeneration. However, this is a lack of knowledge as to how major epigenetic signatures affect post-stroke recovery. The paper systematically reviews the capacity of miRNAs to fine-tune neuroprotective responses and the broader regulatory functions of lncRNAs. Additionally, we examine how shifts in DNA methylation patterns and histone modifications correlate with stroke outcomes, presenting a case for precise epigenetic therapies. In this review, we highlight that these modulators offer promising therapeutic targets for enhancing recovery and provide novel insights into stroke pathology and treatment. We also offer a comparative analysis of the four modulators and present the challenges and future perspectives for each one. The review sets forth a trajectory for future research, underscoring the development of novel epigenetic-based therapeutics as a groundbreaking approach to enhance post-stroke neurorehabilitation and improve patient prognoses.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000115/pdfft?md5=148aa923fa3b4759b5c61bc6be5aeced&pid=1-s2.0-S2543106424000115-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141605452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A brief history of urine examination - From ancient uroscopy to 21st century urinomics 尿液检查简史--从古代尿镜到 21 世纪尿液学
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.06.001
Tatjana Crnogorac-Jurcevic
{"title":"A brief history of urine examination - From ancient uroscopy to 21st century urinomics","authors":"Tatjana Crnogorac-Jurcevic","doi":"10.1016/j.abst.2024.06.001","DOIUrl":"10.1016/j.abst.2024.06.001","url":null,"abstract":"<div><p>The art of uroscopy (Greek <em>ouron</em>-urine and <em>skopeo</em>-examination), the visual inspection of urine, is as old as the history of mankind. It had seen its ups and downs, was praised and derided, but was ultimately perfected to become a complex visual and tasting examination tool. As centuries passed, it was replaced by urinalysis which was first based on iatrochemical principles and then followed by transmutation into modern biochemical analyses. Recent rapid development of sophisticated ‘omics’ technologies opened new avenues for the exploration of this important body fluid. This brief overview will take a journey through this fascinating history and will give a glimpse of what is to come in the future.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000085/pdfft?md5=a44ecb46dac125f0723bb2767ab8b5ad&pid=1-s2.0-S2543106424000085-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141401525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of machine learning algorithms in magnetic resonance imaging (MRI), and biomarkers on early detection of Alzheimer's disease 磁共振成像(MRI)中的机器学习算法和生物标志物对阿尔茨海默病早期检测的影响
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.08.004
{"title":"The effects of machine learning algorithms in magnetic resonance imaging (MRI), and biomarkers on early detection of Alzheimer's disease","authors":"","doi":"10.1016/j.abst.2024.08.004","DOIUrl":"10.1016/j.abst.2024.08.004","url":null,"abstract":"<div><p>Alzheimer's Disease (AD) is a disorder that worsens over time causing loss of memory and decline of cognitive functions. Current methods for diagnosis consist of neuroimaging scans, magnetic resonance imaging (MRI scans), positron emission tomography (PET scans), and identifying biomarkers in cerebrospinal fluid (CSF). New forms of advanced technology such as machine learning are rising to quickly diagnose AD. This work is a comprehensive review of the research that uses machine learning methods to classify AD cases early. It is a study to provide details for MRI scans and biomarkers used for the recognition of AD and evaluates the execution of both applications while using different classifiers. This paper will discuss and compare various machine learning methods that can be implemented for the classification of Alzheimer's disease. The applications of these algorithms (MRI and biomarkers) are also discussed ultimately proposing the best algorithm and application for classification.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000152/pdfft?md5=77c3555be55472654dbe7053a2e97d7c&pid=1-s2.0-S2543106424000152-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142168930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic potential of black seed oil in treating rheumatoid arthritis: Insights on biochemical and genetic analyses of inflammatory signaling transducer 黑籽油治疗类风湿性关节炎的潜力:对炎症信号转导因子的生化和遗传分析的启示
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.09.002
{"title":"Therapeutic potential of black seed oil in treating rheumatoid arthritis: Insights on biochemical and genetic analyses of inflammatory signaling transducer","authors":"","doi":"10.1016/j.abst.2024.09.002","DOIUrl":"10.1016/j.abst.2024.09.002","url":null,"abstract":"<div><div>Nigella sativa (Black seed) has been a longstanding component of traditional medicine. Rheumatoid arthritis, an autoimmune disorder targeting bone, cartilage, and synovial cells, leads to enduring joint damage due to pathological immune responses. This study aims to assess the effectiveness of black seed oil in treating rheumatoid arthritis using a rat model. Fifty male albino rats were randomly assigned to five groups: control, induced arthritis, induced arthritis treated with black seed oil, induced arthritis treated with hydroxychloroquine, and induced arthritis treated with a combination of black seed oil and hydroxychloroquine. Arthritis was induced in the rats using single dose of 0.1 ml of Complete Freunds Adjuvant. Biochemical and genetic analyses of signaling transducers (IFNγ, IL-4, STAT3, and IL-12) were conducted on blood samples and stifle joints. Results indicated that induced arthritis led to elevated serum AST, ALT activities, creatinine, urea, FBS, RF, Anti-CCP, and CRP, along with reduced serum TAC. Additionally, there was an upregulation of IL-12, IFNγ, and STAT3 genes, and a downregulation of IL-4 gene compared to the normal control group. Treatment with black seed oil or hydroxychloroquine individually demonstrated notable improvements in these parameters, although the combined treatment showed less marked improvement. In conclusion, black seed oil demonstrates potential therapeutic benefits in alleviating the negative impacts of rheumatoid arthritis.</div></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142424717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanomedicine in cancer therapy: Advancing precision treatments 癌症治疗中的纳米医学:推进精准治疗
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.06.003
Abdullahi Tunde Aborode , Ayomide Samson Oluwajoba , Aminat Modupe Ibrahim , Shahzaib Ahmad , Aashna Mehta , Osasere Jude-Kelly Osayawe , Damilola Oyebode , Oluwaseun Akinsola , Abraham Osinuga , Isreal Ayobami Onifade , Ibrahim O. Adelakun , Ridwan Olamilekan Adesola , Taiwo Bakare Abidola , Adedeji Daniel Ogunyemi , Oluwaseun Adeolu Ogundijo , Olamilekan Gabriel Banwo , Chibuzo H. Obiechefu
{"title":"Nanomedicine in cancer therapy: Advancing precision treatments","authors":"Abdullahi Tunde Aborode ,&nbsp;Ayomide Samson Oluwajoba ,&nbsp;Aminat Modupe Ibrahim ,&nbsp;Shahzaib Ahmad ,&nbsp;Aashna Mehta ,&nbsp;Osasere Jude-Kelly Osayawe ,&nbsp;Damilola Oyebode ,&nbsp;Oluwaseun Akinsola ,&nbsp;Abraham Osinuga ,&nbsp;Isreal Ayobami Onifade ,&nbsp;Ibrahim O. Adelakun ,&nbsp;Ridwan Olamilekan Adesola ,&nbsp;Taiwo Bakare Abidola ,&nbsp;Adedeji Daniel Ogunyemi ,&nbsp;Oluwaseun Adeolu Ogundijo ,&nbsp;Olamilekan Gabriel Banwo ,&nbsp;Chibuzo H. Obiechefu","doi":"10.1016/j.abst.2024.06.003","DOIUrl":"https://doi.org/10.1016/j.abst.2024.06.003","url":null,"abstract":"<div><p>The progress made in the field of nanotechnology has resulted in the development of nanomedicine agents, which have demonstrated their efficacy as a promising clinical tool in the fight against different types of cancers. Furthermore, Nanomedicine products possess the potential to achieve intricate targeting strategies and multifunctionality. Currently, nanoparticles possess diverse applications across various scientific disciplines and serve as a crucial component in contemporary medical practices. The specimens have undergone analysis for diverse clinical purposes, including serving as drug carriers, delivering tumor genes, and functioning as contrast compounds in imaging. Diverse nanomaterials derived from organic, inorganic, lipid, or glycan compounds, in addition to synthetic polymers, have been employed to advance and enhance novel cancer therapeutics. The present review centers on the utilization of nanoparticles in clinical settings for the purposes of cancer diagnosis and treatment, with a particular emphasis on their function as drug carriers and targeted therapy agents.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000103/pdfft?md5=047f325cd4a8218462e22114585218a1&pid=1-s2.0-S2543106424000103-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141484836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leveraging lean 4.0 technologies in healthcare: An exploration of its applications 在医疗保健领域利用精益 4.0 技术:应用探索
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.08.001
{"title":"Leveraging lean 4.0 technologies in healthcare: An exploration of its applications","authors":"","doi":"10.1016/j.abst.2024.08.001","DOIUrl":"10.1016/j.abst.2024.08.001","url":null,"abstract":"<div><p>Lean 4.0, a fusion of lean manufacturing and digital technologies, is a powerful tool for implementing Industry 4.0. Its widespread use across sectors is driven by its ability to eliminate waste, reduce errors, boost revenue, and enhance customer care and efficiency. In the healthcare sector, this fourth lean revolution is particularly beneficial, as it helps to curb wastage and enhance efficiency, leading to more effective outcomes. Lean 4.0, a globally recognized best practice for industrial organisations, has proven its worth in enhancing performance and competitiveness. Its success has led to its adoption not only in manufacturing but also in non-manufacturing sectors such as Healthcare, finance, telecommunications, construction, and logistics. Its ease of use and effectiveness make it a superior alternative to traditional medical waste management techniques. Relevant papers on Lean 4.0 for Healthcare in the current literature are identified and studied to evaluate the impact of Lean 4.0 principles in Healthcare. This review-based research studies Lean 4.0 technologies and their needs in Healthcare. It discusses sustainable support for the healthcare sphere through Lean 4.0. Paper briefs several modalities of Lean 4.0 for the healthcare domain. Finally, the paper identifies and discusses the significant applications of Lean 4.0 in Healthcare. Lean 4.0 is essential to lowering errors that lead to medical mistakes since this business deals with life-or-death situations. Healthcare institutions need to reduce their overall waste reduction. With Lean 4.0, staff members working in quality management, clinical operations, consulting, and patient experience can progress into leadership roles in the healthcare sector. Lean 4.0 technologies can reduce waste production, including employing reusable medical equipment or cutting down on packaging waste. The possible difficulty of integrating digital technologies with healthcare systems and practices is Lean 4.0's limitations for the healthcare industry. Healthcare institutions can use refillable syringes and other disposable items to reduce waste rather than disposable plastic syringes. In future, healthcare institutions may save costs and lessen their environmental effect by minimising trash by using lean 4.0 technologies.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000127/pdfft?md5=cb3207d4120894b22c39ecd012cbb1b4&pid=1-s2.0-S2543106424000127-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring fucosylation in lung cancer: Mechanisms, diagnosis, and therapeutic strategies 探索肺癌中的岩藻糖基化:机制、诊断和治疗策略
Advances in biomarker sciences and technology Pub Date : 2024-01-01 DOI: 10.1016/j.abst.2024.08.005
{"title":"Exploring fucosylation in lung cancer: Mechanisms, diagnosis, and therapeutic strategies","authors":"","doi":"10.1016/j.abst.2024.08.005","DOIUrl":"10.1016/j.abst.2024.08.005","url":null,"abstract":"<div><p>Lung cancer remains a global health crisis, responsible for significant morbidity and mortality. Late-stage diagnosis often limits treatment options and patient survival. Therefore, identifying reliable and sensitive biomarkers for early detection is crucial. Glycosylation, the addition of glycans to protein/RNA/lipid, is a vital cellular process. Normal glycosylation regulates healthy cell function, while alterations, particularly in fucosylation and sialylation, contribute to lung cancer development and progression. These aberrant glycosylation patterns are associated with processes such as immune modulation, cell migration, proliferation, and cell-cell recognition. Fucosylation, a specific type of glycosylation, is frequently altered in lung cancer, with high levels detected in tumors. Understanding the mechanisms behind this altered fucosylation holds immense potential. It can pave the way for the development of novel therapeutic and diagnostic tools for lung cancer. By analyzing specific fucosylation patterns in bodily fluids, it could lead to early-stage diagnosis. This review delves into the mechanisms of fucosylation in lung cancer initiation and metastasis, proposing promising strategies to target the mechanisms, aiming to inhibit tumor growth and disease progression.</p></div>","PeriodicalId":72080,"journal":{"name":"Advances in biomarker sciences and technology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2543106424000164/pdfft?md5=d7bd869d5f29eb7c6e155b9974fa10d6&pid=1-s2.0-S2543106424000164-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142151316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信